ICD therapy in women: Are men from Mars and women from Venus?

Heart Rhythm

Volumn 7, Issue 7, 2010, Pages 883-884

  Ghanbari, Hamid ^a   Machado, Christian ^a  

^a PROVIDENCE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRHYTHMOGENESIS; COMORBIDITY; DEFIBRILLATOR; DISEASE PREDISPOSITION; EDITORIAL; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART REPOLARIZATION; HUMAN; INCIDENCE; MORTALITY; PRIORITY JOURNAL; SEX DIFFERENCE; SUDDEN DEATH; SYSTOLIC DYSFUNCTION;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHY, DILATED; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; SEX FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77953915272     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2010.04.024     Document Type: Editorial

References (25)

1. Lloyd-Jones D., Adams R.J., Brown T.M., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121 (2010) e46-e215
2. Hunt S.A., Abraham W.T., Chin M.H., et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (2009) e391-e479
3. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
4. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
5. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
6. Hammill S.C., Kremers M.S., Kadish A.H., et al. Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm 6 (2009) 1397-1401
7. Russo A.M., Poole J.E., Mark D.B., et al. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol 19 (2008) 720-724
8. Zareba W., Moss A.J., Jackson Hall W., et al. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 16 (2005) 1265-1270
9. Dhruva S.S., and Redberg R.F. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. Arch Intern Med 168 (2008) 136-140
10. Curtis L.H., Al-Khatib S.M., Shea A.M., Hammill B.G., Hernandez A.F., and Schulman K.A. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 298 (2007) 1517-1524
11. Peterson P.N., Daugherty S.L., Wang Y., et al. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation 119 (2009) 1078-1084
12. Ghanbari H., Dalloul G., Hasan R., et al. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med 169 (2009) 1500-1506
13. Santangelli P., Pelargonio G., Dello Russo A., et al. Gender differences In clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm 7 (2010) 876-882
14. Haigney M.C., Zareba W., Nasir J.M., et al. Gender differences and risk of ventricular tachycardia or ventricular fibrillation. Heart Rhythm 6 (2009) 180-186
15. Dash R., Frank K.F., Carr A.N., Moravec C.S., and Kranias E.G. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium. J Mol Cell Cardiol 33 (2001) 1345-1353
16. Vizgirda V.M., Wahler G.M., Sondgeroth K.L., Ziolo M.T., and Schwertz D.W. Mechanisms of sex differences in rat cardiac myocyte response to beta-adrenergic stimulation. Am J Physiol Heart Circ Physiol 282 (2002) H256-H263
17. Song M., Helguera G., Eghbali M., et al. Remodeling of Kv4.3 potassium channel gene expression under the control of sex hormones. J Biol Chem 276 (2001) 31883-31890
18. Nakagawa M., Ooie T., Ou B., et al. Gender differences in autonomic modulation of ventricular repolarization in humans. J Cardiovasc Electrophysiol 16 (2005) 278-284
19. Wei S.K., McCurley J.M., Hanlon S.U., and Haigney M.C. Gender differences in Na/Ca exchanger current and beta-adrenergic responsiveness in heart failure in pig myocytes. Ann N Y Acad Sci 1099 (2007) 183-189
20. Hara M., Danilo Jr. P., and Rosen M.R. Effects of gonadal steroids on ventricular repolarization and on the response to E4031. J Pharmacol Exp Ther 285 (1998) 1068-1072
21. Chen Y.J., Lee S.H., Hsieh M.H., et al. Effects of 17beta-estradiol on tachycardia-induced changes of atrial refractoriness and cisapride-induced ventricular arrhythmia. J Cardiovasc Electrophysiol 10 (1999) 587-598
22. Stumpf W.E., Sar M., and Aumuller G. The heart: a target organ for estradiol. Science 196 (1977) 319-321
23. Frazier C.G., Alexander K.P., Newby L.K., et al. Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials. J Am Coll Cardiol 49 (2007) 1450-1458
24. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 119 (1993) 1187-1197
25. Myerburg R.J., Mitrani R., Interian Jr. A., and Castellanos A. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation 97 (1998) 1514-1521